European Healthtech startup funding raised during Q1 2025.
In Q1 2025, 113 European Healthtech companies raised a combined €2.5B across 113 funding rounds, up 158.1% versus Q1 2024. UK led by capital raised, and Bayern Kapital was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Other | Mar 2025 | €555M |
| Verdiva Bio | Series A | Jan 2025 | €399M |
| Neko Health | Series B | Jan 2025 | €250M |
| Cera | Other | Jan 2025 |
6 exits.
| €150M |
| CeQur | Other | Jan 2025 | €116M |
| Fire1 | Other | Jan 2025 | €115M |
| Orbis Medicines | Series A | Jan 2025 | €90M |
| Leyden Labs | Other | Jan 2025 | €68M |
| Maxion Therapeutics | Series A | Mar 2025 | €66M |
| Numab | Series C | Jan 2025 | €53M |
| Quibim | Series A | Jan 2025 | €50M |
| Coave Therapeutics | Series A | Jan 2025 | €32M |
| Deciphex | Series C | Jan 2025 | €31M |
| Avelios Medical | Series A | Feb 2025 | €30M |
| Germitec | Other | Feb 2025 | €29M |
